PL1819698T3 - Pochodne 1-[(6-podstawione alkoksychinoksalinylo)aminokarbonylo]-4-(hetero)arylopiperazyny - Google Patents
Pochodne 1-[(6-podstawione alkoksychinoksalinylo)aminokarbonylo]-4-(hetero)arylopiperazynyInfo
- Publication number
- PL1819698T3 PL1819698T3 PL05809031T PL05809031T PL1819698T3 PL 1819698 T3 PL1819698 T3 PL 1819698T3 PL 05809031 T PL05809031 T PL 05809031T PL 05809031 T PL05809031 T PL 05809031T PL 1819698 T3 PL1819698 T3 PL 1819698T3
- Authority
- PL
- Poland
- Prior art keywords
- aminocarbonyl
- hetero
- arylpiperazine derivatives
- alkoxyquinoxalinyl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040094232A KR20060053788A (ko) | 2004-11-17 | 2004-11-17 | 1-[(2-알콕시-6-치환-퀴녹살린-3-일)아미노카르보닐]-4-(헤테로)아릴피페라진 유도체 |
KR1020040094233A KR100739233B1 (ko) | 2004-11-17 | 2004-11-17 | 1-[(3-알콕시-6-치환-퀴녹살린-2-일)아미노카르보닐]-4-(헤테로)아릴피페라진 유도체 |
PCT/KR2005/003463 WO2006054830A1 (en) | 2004-11-17 | 2005-10-18 | 1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives |
EP05809031A EP1819698B1 (en) | 2004-11-17 | 2005-10-18 | 1-[(6-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1819698T3 true PL1819698T3 (pl) | 2011-08-31 |
Family
ID=36407350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05809031T PL1819698T3 (pl) | 2004-11-17 | 2005-10-18 | Pochodne 1-[(6-podstawione alkoksychinoksalinylo)aminokarbonylo]-4-(hetero)arylopiperazyny |
Country Status (12)
Country | Link |
---|---|
US (2) | US8314100B2 (pl) |
EP (1) | EP1819698B1 (pl) |
JP (1) | JP6097946B2 (pl) |
CN (1) | CN103524436B (pl) |
AT (1) | ATE499366T1 (pl) |
AU (1) | AU2005307209B2 (pl) |
BR (1) | BRPI0517734A (pl) |
CA (1) | CA2587891C (pl) |
DE (1) | DE602005026557D1 (pl) |
MX (1) | MX2007005863A (pl) |
PL (1) | PL1819698T3 (pl) |
WO (1) | WO2006054830A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8314100B2 (en) | 2004-11-17 | 2012-11-20 | Rexahn Pharmaceuticals, Inc. | 1-[6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives |
KR101140133B1 (ko) | 2010-02-17 | 2012-05-02 | 한국화학연구원 | 1-(6,7-다이플루오르-3-메톡시퀴녹살린-2-일)-3-[1-(헤테로아릴메틸)피페리딘-4-일] 우레아 유도체, 그 제조방법 및 그의 용도 |
MX363378B (es) * | 2013-06-28 | 2019-03-21 | Rexahn Pharmaceuticals Inc | Composiciones nanoparticuladas y formulaciones de compuestos de piperazina. |
US10059721B2 (en) | 2014-12-08 | 2018-08-28 | Dongguk University Industry-Academic Cooperation Foundation | Substituted thieno[3,2-b]pyrazines for inhibiting cancer cell proliferation and inducing cancer cell apoptosis |
US9969698B2 (en) | 2015-09-04 | 2018-05-15 | Rexahn Pharmaceuticals, Inc. | Quinoxalinyl-piperazinamide methods of use |
KR101872645B1 (ko) * | 2016-06-09 | 2018-08-03 | 동국대학교 산학협력단 | 신규한 4-(아릴)-N-(3-알콕시퓨로[2,3-b]피라진-2-일)-피페라진-1-카복스아미드 유도체 및 이의 항증식 효과 |
WO2017213452A1 (ko) * | 2016-06-09 | 2017-12-14 | 동국대학교 산학협력단 | 신규한 4-(아릴)-n-(3-알콕시퓨로[2,3-b]피라진-2-일)-피페라진-1-카복스아미드 유도체 및 이의 항증식 효과 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL59104A (en) * | 1979-02-09 | 1984-02-29 | Roussel Uclaf | Heterotricyclic derivatives,process for their preparation and pharmaceutical compositions incorporating them |
FR2448541A1 (fr) * | 1979-02-09 | 1980-09-05 | Roussel Uclaf | Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
US6028184A (en) * | 1996-12-31 | 2000-02-22 | Max-Plank-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Pax6 and Pax4 nucleic acid mixtures |
US6028195A (en) * | 1996-06-29 | 2000-02-22 | Samjin Pharmaceutical Co., Ltd. | Piperazine derivatives and process for the preparation thereof |
DE60010988T2 (de) | 1999-03-03 | 2005-06-09 | Samjin Pharmaceutical Co., Ltd. | Piperazinderivate und verfahren zu ihrer herstellung |
AU2001264376A1 (en) * | 2000-06-15 | 2001-12-24 | Chaconne Nsi Co., Ltd. | Urea derivative useful as an anti-cancer agent and process for preparing same |
AR043059A1 (es) * | 2002-11-12 | 2005-07-13 | Bayer Pharmaceuticals Corp | Derivados de indolil pirazinona utiles para el tratamiento de trastornos hiper-proliferativos |
CA2522079A1 (en) * | 2003-04-16 | 2004-11-04 | Astrazeneca Ab | Quinazoline derivatives for treatment of cancer |
US8314100B2 (en) | 2004-11-17 | 2012-11-20 | Rexahn Pharmaceuticals, Inc. | 1-[6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives |
-
2005
- 2005-10-18 US US11/667,923 patent/US8314100B2/en active Active
- 2005-10-18 WO PCT/KR2005/003463 patent/WO2006054830A1/en active Application Filing
- 2005-10-18 JP JP2007542886A patent/JP6097946B2/ja not_active Expired - Fee Related
- 2005-10-18 AT AT05809031T patent/ATE499366T1/de active
- 2005-10-18 MX MX2007005863A patent/MX2007005863A/es active IP Right Grant
- 2005-10-18 PL PL05809031T patent/PL1819698T3/pl unknown
- 2005-10-18 AU AU2005307209A patent/AU2005307209B2/en not_active Ceased
- 2005-10-18 CN CN201310540633.7A patent/CN103524436B/zh not_active Expired - Fee Related
- 2005-10-18 CA CA2587891A patent/CA2587891C/en not_active Expired - Fee Related
- 2005-10-18 EP EP05809031A patent/EP1819698B1/en not_active Not-in-force
- 2005-10-18 DE DE602005026557T patent/DE602005026557D1/de active Active
- 2005-10-18 BR BRPI0517734-0A patent/BRPI0517734A/pt not_active Application Discontinuation
-
2012
- 2012-10-26 US US13/661,975 patent/US8598173B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2008520653A (ja) | 2008-06-19 |
US8314100B2 (en) | 2012-11-20 |
EP1819698A1 (en) | 2007-08-22 |
BRPI0517734A (pt) | 2008-10-21 |
US20080318963A1 (en) | 2008-12-25 |
DE602005026557D1 (de) | 2011-04-07 |
US20130053390A1 (en) | 2013-02-28 |
ATE499366T1 (de) | 2011-03-15 |
MX2007005863A (es) | 2007-10-19 |
US8598173B2 (en) | 2013-12-03 |
CN103524436B (zh) | 2015-09-23 |
WO2006054830A1 (en) | 2006-05-26 |
CA2587891A1 (en) | 2006-05-26 |
CA2587891C (en) | 2010-08-31 |
AU2005307209A1 (en) | 2006-05-26 |
AU2005307209B2 (en) | 2009-11-19 |
CN103524436A (zh) | 2014-01-22 |
EP1819698B1 (en) | 2011-02-23 |
JP6097946B2 (ja) | 2017-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY139446A (en) | Novel quinoline derivatives | |
WO2002055496A8 (en) | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression | |
TW200640900A (en) | 1-(2h)-isoquinolone derivative | |
DE60318193D1 (en) | Phenethanolaminderivate | |
TNSN06409A1 (en) | Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof | |
MXPA06009475A (es) | Derivados de quinazolina y usos terapeuticos de los mismos. | |
MY139302A (en) | Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
DE60315492D1 (de) | Medizinisch verwendbare arylethanolamin verbindungen | |
TW200833675A (en) | Nicotinamide derivatives | |
MY139303A (en) | Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
UA86977C2 (ru) | Производные гидантоина для лечения обструктивных болезней дыхательных путей | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
TNSN05194A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
EA200801909A1 (ru) | Соединения пиридина для лечения заболеваний, опосредованных действием простагландина | |
MX2008001606A (es) | Piperazinas substituidas como antagonistas de receptor de glutamato metabotropico. | |
TW200612936A (en) | Indole derivatives | |
MX2007006387A (es) | Derivados de piridina 3-substituidos como antagonistas h3. | |
PL1819698T3 (pl) | Pochodne 1-[(6-podstawione alkoksychinoksalinylo)aminokarbonylo]-4-(hetero)arylopiperazyny | |
MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
ES2193875A1 (es) | Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos. | |
MXPA04005209A (es) | Antagonistas del receptor de adenosina a2a. | |
WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
MXPA04006033A (es) | Dicetopiperacinas sustituidas como antagonistas de oxitocina. | |
HK1079526A1 (en) | A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin |